tiprankstipranks
Enfusion (ENFN)
NYSE:ENFN
US Market
Holding ENFN?
Track your performance easily

Enfusion (ENFN) Financial Statements

32 Followers

Enfusion Financial Overview

Enfusion's market cap is currently ―. The company's EPS TTM is $0.026; its P/E ratio is 405.73; Enfusion is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 51.17M$ 49.45M$ 48.05M$ 46.49M$ 44.36M
Gross Profit$ 34.83M$ 33.49M$ 31.88M$ 30.86M$ 29.85M
EBIT$ 2.86M$ 9.04M$ 5.67M$ 2.13M$ 3.03M
EBITDA$ 5.88M$ 11.97M$ 8.41M$ 5.65M$ 5.55M
Net Income Common Stockholders$ 1.42M$ 1.83M$ -539.00K$ 623.00K$ 1.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 48.30M$ 34.45M$ 32.89M$ 35.60M$ 31.65M
Total Assets$ 134.94M$ 120.09M$ 110.96M$ 108.97M$ 101.74M
Total Debt$ 21.13M$ 18.00M$ 15.46M$ 15.44M$ 16.49M
Net Debt$ -27.17M$ -16.45M$ -17.43M$ -20.17M$ -15.16M
Total Liabilities$ 38.76M$ 30.68M$ 28.34M$ 31.49M$ 28.46M
Stockholders Equity$ 69.92M$ 64.27M$ 58.05M$ 53.67M$ 50.73M
Cash Flow-
Free Cash Flow$ 15.06M$ 6.31M$ 898.00K$ 4.29M$ 11.15M
Operating Cash Flow$ 16.16M$ 7.31M$ 1.53M$ 6.59M$ 12.11M
Investing Cash Flow$ -2.77M$ -5.71M$ -2.75M$ -2.29M$ -2.61M
Financing Cash Flow$ -14.00K$ -16.00K$ -1.37M$ -579.00K$ -5.31M
Currency in USD

Enfusion Earnings and Revenue History

Enfusion Debt to Assets

Enfusion Cash Flow

Enfusion Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis